Islet cell-specific autoantibodies in children with insulin-dependent diabetes mellitus and their siblings at clinical manifestation of the disease

European Journal of Endocrinology

Volumn 135, Issue 6, 1996, Pages 689-695

  Vähäsalo, Paula ^a   Knip, Mikael ^a   Karjalainen, Jukka ^a   Tuomilehto Wolf, Eva ^b   Lounamaa, Raisa ^b   Åkerblom, Hans K ^c  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHILD; FAMILY; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCREENING; SIBLING;

EID: 0030483737     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350689     Document Type: Article

References (40)

1. Bottazzo, GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974;2:1279-82
2. MacCuish AC, Barnes EW, Irvine WJ, Duncan LIP. Antibodies to pancreatic islet cells in insulin-dependent diabetes with coexistent autoimmune disease. Lancet 1974;2:1529-31
3. Lendrum R, Walker G, Gamble DR. Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet 1975;1:880-3
4. Lendrum R, Walker G, Cudworth AG, Theophanides C, Pyke DA, Bloom A, et al. Islet-cell antibodies in diabetes mellitus. Lancet 1976;2:1273-6
5. Pujol-Borrell R, Richart C, Martin C, Martinez-Vazquez JM, Bottazzo GF. Islet cell antibodies in Spanish diabetics. Lancet 1978;2:268-9
6. Barbosa J, Chavers B, Dunsworth T, Michael A, Islet cell antibodies and histocompatibility antigens (HLA) in insulin-dependent diabetics and their first degree relatives. Diabetes 1982;31:585-8
7. Mustonen A, Knip M, Huttunen NP, Puukka R, Käär ML, Akerblom HK. Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies. Diabetologia 1984;27: 421-6
8. Karjalainen J, Knip M, Mustonen A, Ilonen J, Åkerblom HK. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM. Diabetes 1986;35: 620-2
9. Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, et al. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet 1981;2:1363-5
10. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS. First-degree relatives of patients with type I diabetes. Islet-cell antibodies and abnormal insulin secretion. N Engl J Med 1985; 313:461-4
11. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990;335:147-9
12. McCulloch DK, Klaff LJ, Kahn SE, Schoenfeld SL, Greenbaum CJ, Mauseth RS, et al. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. Diabetes 1990;39:549-56
13. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990;323:1167-72
14. Wilkin T, Hoskins PJ, Armitage M, Rodier M, Casey C, Diaz JL. et al. Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet 1985;1:480-2
15. Arslanian SA, Becker DJ, Rabin B, Atchison, R, Eberhardt M, Cavender D, et al. Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes 1985;34:926-30
16. Srikanta S, Ricker AT, McCulloch DK, Soeldner JS, Eisenbarth GS, Palmer JP. Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus. Diabetes 1986;35:139-42
17. McEvoy RC, Witt ME, Ginsberg-Fellner F, Rubinstein P. Anti-insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement Diabetes 1986;35:634-41
18. Atkinson MA, Maclaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP. Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 1986;35:894-8
19. Dean BM, Becker F, McNally JM, Tarn AC, Schwartz G, Gale EAM, et al. Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia 1986;29:339-42
20. Zancheta R, Russo V, Presotto F, Magrin L, Pedini B, Betterle C. Detection of insulin autoantibodies using an ELISA technique in first-degree relatives of IDDM patients and in autoimmune patients. Diabetes Res 1987;6:189-94
21. Kuglin B, Kolb H, Greenbaum C, Maclaren NK, Lernmark Å, Palmer JP. The fourth international workshop on the standardisation of insulin autoantibody measurement. Diabetologia 1990; 33:638-9
22. Helmke K, Otten A, Willems W. Islet cell antibodies in children with mumps infection [letter]. Lancet 1980;2:211-2
23. Helmke K, Otten A, Willems WR, Brockhaus R, Mueller-Eckhardt G, Stief T, et al. Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination. Diabetologia 1986;29:30-3
24. Bodansky HJ, Grant PJ, Dean BM, McNally J, Bottazzo GF, Hambling MH, et al. Islet-cell antibodies and insulin autoantibodies in association with common viral infections. Lancet 1986; 2:1351-3
25. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, Reunanen A, Virtala E, Kaprio EA, et al. Epidemiology of childhood diabetes mellitus in Finland - background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992;35:70-6
26. Lernmark A, Molenaar JL, van Beers WA, Yamaguchi Y, Nagataki S, Ludvigsson J. et al. The fourth international serum exchange workshop to standardize cytoplasmic islet cell antibodies. Diabetologia 1991;34:534-5
27. Vähäsalo P. Autoantibodies to insulin have similar affinity to that of antibodies to exogenous insulin but lower binding capacity. Eur J Clin Ivest 1992;22:772-6
28. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK. et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983;222:1337-9
29. Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975;11:541-8
30. Karjalainen J, Knip M, Mustonen A, Åkerblom HK. Insulin autoantibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes - a poor predictor of clinical course and antibody response to exogenous insulin. Diabetologia 1988;31:129-33
31. Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R, the DiMe Study Group. New susceptibility haplotype for Type 1 diabetes. Lancet 1989;2:299-302
32. Morris JA, Gardner MJ. Calculating confidence intervals for relative risks, odds ratios, and standardised ratios and rates. In: Gardner MJ, Altman DG, editors. Statistics with confidence. Confidence intervals and statistical guidelines. London: British Medical Journal, 1989;50:63
33. Rayner ML, Harrison LC, Campbell IL, Heyma P, Cook JJ. Detection of insulin antibodies in newly-diagnosed type 1 diabetic children after "acid-stripping" of sera. Diabetes Res 1987;6:1-4
34. Tillil H. Köbberling J. Age-correlated empirical genetic risk estimates for first degree relatives of IDDM patients. Diabetes 1987;36:93-9
35. Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Bottazzo GF, et al. Predicting insulin-dependent diabetes. Lancet 1988;1: 845-50
36. Lorenzen T, Pociot F, Hougaard P, Nerup J. Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 1994;37:321-7
37. Ziegler R, Apler CA, Awdeh ZL, Castaño L, Brink SJ, Soeldner JS, et al. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type 1 diabetes. Diabetes 1991;40:709-14
38. Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M. A comparison of childhood and adult type 1 diabetes mellitus. N Engl J Med 1989;320:881-6
39. Hyöty H, Hiltunen M, Knip M, Laakkonen M, Vähäsalo P, Karjalainen J, et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995;44:652-7
40. Hyöty H, Hiltunen M, Knip M, Ilonen J, Laakkonen M, Roivainen M, et al. Induction of beta-cell damage by enterovirus infections - a prospective study [Abstract]. Diabetologia 1995;38 Suppl 1:A16